BioRevolution is a biopharmaceutical company dedicated to building, restoring, and preserving muscle mass and strength for Longevity. Our approach harnesses the body’s natural, evolutionary mechanism of building functional muscle with broad applicability across multiple muscle wasting diseases, including Glycogen Storage Disorders, Muscular Dystrophies, Obesity, and Sarcopenia.

The company’s lead program, BREV-100, is a first-in-class, oral small molecule designed to activate the body’s central mechanism of building functional muscle starting with Pompe disease, where excess glycogen drives progressive muscle impairment.

BioRevolution is led by a seasoned team that has advanced multiple innovative therapies into the clinic and is united by a mission to transform muscle biology and extend healthy human lifespan for millions of patients living with rare and chronic diseases.

BioRevolution

Org chart

Teams

Offices

BioRevolution

Org chart

Teams

Offices

Related companies